HDAC9 and neoplasm: Thus, this review will firstly provide a brief overview of the effects of acetylation on gene expression and tumor phenotype, elaborate the antitumor mechanism of HDAC inhibitors, and then outline several of these promising HDACis that are in pre-clinical and clinical studies in GBM as monotherapies and combination therapies.